Ryan Cleary, MD
Radiation Oncology · Chattanooga, TNNPI 1609210269
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Novocure Inc. at 58.3% of the total. Reporting peaked in 2020 at $2,292 and has fallen 69.9% since, to $690 in 2025.
Across 50 payments — averaging $75.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$2K
- Boston Scientific$222
- AstraZeneca$214
- Siemens Medical Solutions USA, Inc.$141
- Galvanize Therapeutics, Inc$130
- Monteris Medical Corporation$122
- plus $754 from 16 others
What the payments were for
- Consulting fees$2,00053%
- Food & beverage$1,69245%
- Education$1003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 11 | $2,210 |
| Boston Scientific | 3 | $222 |
| AstraZeneca | 3 | $214 |
| Siemens Medical Solutions USA, Inc. | 2 | $141 |
| Galvanize Therapeutics, Inc | 1 | $130 |
| Monteris Medical Corporation | 1 | $122 |
| Bayer | 6 | $109 |
| Johnson & Johnson | 1 | $100 |
| GSK | 1 | $97 |
| Pfizer | 4 | $92 |
| Tactile Systems Technology Inc | 4 | $83 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| Angiodynamics, Inc. | 2 | $39 |
| Teleflex LLC | 1 | $31 |
| Accuray Incorporated | 1 | $23 |
| Amgen | 1 | $22 |
| Progenics Pharmaceuticals, Inc. | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Novartis | 1 | $17 |
| Brainlab, Inc. | 1 | $14 |
| Blue Earth Diagnostics | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oncology$2,000
- GENERAL MALE SUI$148
- ALIYA SYSTEM$130
- Bravos Afterloader System$122
- Edge$122
- Neuroblate$122
- LYNPARZA$111
How this compares
$3,792 in reported general payments places this provider in the 80th percentile of 115 radiation oncology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 27 | $599 |
| Tamsulosin Hcl | 45 | $516 |
| Oxycodone Hcl | 11 | $488 |
| Dexamethasone | 34 | $436 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $392 |
| Lidocaine Hcl ViscousLidocaine Hcl | 25 | $244 |
| Ondansetron Hcl | 12 | $234 |
| Olanzapine | 18 | $114 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Chattanooga
- Frank KimseyChattanooga$5K
- Austin DoveChattanooga$5K
- Jonathan WhaleyChattanooga$2K
- Nitesh RanaChattanooga$940
- John FortneyChattanooga$645
- Marcus WagnerChattanooga$626
- Patrick WilliamsChattanooga$605
- Han-Chih ChangNashville$66K
- Karen WinkfieldNashville$53K
- James GrayNashville$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.